Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 39-43

  Lachin, John M ^a   Orchard, Trevor J ^b   Nathan, David M ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ALBUMINURIA; ANATOMICAL CONCEPTS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETES CONTROL AND COMPLICATIONS TRIAL; ECHOGRAPHY; EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS STUDY; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE DIABETES THERAPY; LONG TERM CARE; TYPES OF STUDY; ADOLESCENT; ADULT; AGED; BLOOD; CALCINOSIS; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; CALCINOSIS; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84892409974     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2116     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Lachin J, Genuth S, Nathan D, Davis M; The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389
3. Lachin JM, Genuth S, Nathan DM, Zinman B,Rutledge BN; DCCT/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trialdrevisited. Diabetes 2008;57:995-1001
4. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167
5. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528-2538
6. Orchard TJ, Costacou T. When are type 1 diabetic patients at risk for cardiovascular disease Curr Diab Rep 2010;10:48-54
7. Snell-Bergeon JK, Nadeau K. Cardiovascular disease risk in young people with type 1 diabetes. J Cardiovasc Transl Res 2012;5:446-462
8. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75:894-903
9. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
10. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.Effect of intensive diabetes treatment on carotid artery wall thickness in the Epidemiology of Diabetes Interventions and Complications. Diabetes 1999;48:383-390
11. Nathan DM, Lachin J, Cleary P, et al.;Diabetes Control and Complications Trial;Epidemiology of Diabetes Interventions and Complications Research Group.Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl JMed 2003;348:2294-2303
12. Polak JF, Backlund JYC, Cleary PA, et al.;DCCT/EDIC Research Group. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diabetes 2011;60:607-613
13. Cleary PA, Orchard TJ, Genuth S, et al.;DCCT/EDIC Research Group. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 2006;55:3556-3565
14. Turkbey EB, Backlund JYC, Genuth S, et al.;DCCT/EDIC Research Group. Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation 2011;124:1737-1746
15. Turkbey EB, Redheuil A, Backlund JY, et al.;DCCT/EDIC Research Group. Aortic distensibility in type 1 diabetes. Diabetes Care 2013;36:2380-2387
16. Genuth SM, Backlund J-YC, BaylessM, et al.; DCCT/EDIC Research Group. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC. Diabetes 2013;62:3561-3569
17. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
18. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
19. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 2008;359:1577-1589 Kidney Diseases Kidney Diseases